Freedom Pathology Partners
Freedom Pathology Partners is a specialty cancer diagnostic laboratory operating within the Emeritus Medical Technology network, providing pathology, infectious disease, and pharma testing services to healthcare providers and patients on a regional basis.
- Company typePrivate
- Founded2014
- HeadquartersConshohocken, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Freedom Pathology Partners does
Freedom Pathology Partners is a specialty clinical pathology laboratory that provides diagnostic testing to guide the diagnosis and treatment of cancer patients. The company operates as one of two core laboratories within the Emeritus Medical Technology network (the other being EmeritusDX), delivering services through a regional distribution model to enterprise healthcare providers and patients across the United States, with headquarters in Conshohocken, Pennsylvania.
The company's core offering spans five pathology specialties — dermatopathology (DermPath), gastroenterology, hematopathology, urology, and women's health — supplemented by a line of branded infectious disease tests (GI Detect, STIDX, UTIDX, WoundDX, and Respiratory). Beyond diagnostic testing, the company has extended into Pharma Services, offering Informatics and Lab Services aimed at pharmaceutical research and development customers. Digital infrastructure supporting the lab operations includes the Emeritrak patient portal, a client portal for account management, comprehensive test menus, and requisition forms, positioning the company as a digitally enabled reference laboratory.
Freedom Pathology Partners' business model is a fee-for-service diagnostic testing operation, though pricing is not publicly disclosed. Its go-to-market relies on direct laboratory testing to healthcare providers and referring physicians via a regional footprint, with marketing conducted through the client portal, resource guides, test menus, and requisitions. The company is led by CEO Robert Embree, is a privately held for-profit entity founded in 2014, and operates as a subsidiary of Emeritus Medical Technology. The company employs between 11 and 50 people based on disclosed firmographic data.
Freedom Pathology Partners firmographics
Firmographics- Name
- Freedom Pathology Partners
- Website
- https://freedompathology.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Freedom Pathology Partners is a specialty cancer diagnostic laboratory operating within the Emeritus Medical Technology network, providing pathology, infectious disease, and pharma testing services to healthcare providers and patients on a regional basis.
- Ownership category
- akta.pro rank
Freedom Pathology Partners industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)
- akta.pro secondary industries
- Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Freedom Pathology Partners is headquartered
LocationHeadquarters
- HQ city
- Conshohocken
- HQ country
- United States
- HQ region
- North America
Markets served
Freedom Pathology Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Distribution channels1 record
Marketing channels3 records
Freedom Pathology Partners product offering
Product offeringCore offering
Freedom Pathology Partners operates a world-class cancer diagnostic laboratory as part of the EmeritusDX network under Emeritus Medical Technology. The company performs diagnostic testing that guides the diagnosis and treatment of cancer patients across multiple specialties including dermatopathology, gastroenterology, hematopathology, urology, and women's health. It also provides infectious disease testing and pharmaceutical informatics and lab services.
Product overview
Freedom Pathology Partners is a world-class cancer diagnostic laboratory operating as part of EmeritusDX's network of laboratories. The company offers a comprehensive portfolio of pathology services spanning dermatopathology, gastroenterology, hematopathology, urology, and women's health. Additionally, it provides infectious disease testing including GI Detect, STIDX, UTIDX, WoundDX, and Respiratory panels. Pharma Services include Informatics and Lab Services for pharmaceutical research. Patients and clients access services through Emeritrak portal, requisitions, and a comprehensive test menu. The company focuses on delivering actionable clinical information through innovative non-invasive, early detection, precision medicine, and personalized treatment solutions.
Differentiator
Problem solved
Functional benefit
Companies that use Freedom Pathology Partners
Customer profileSegments1 record
Ideal customer profiles2 records
Freedom Pathology Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Freedom Pathology Partners partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights3 records
Freedom Pathology Partners competitors and assessment
Company assessmentDirect peers
- Foundation Medicine: Specialty cancer genomics lab providing comprehensive tumor profiling used to guide personalized treatment decisions. Highly comparable mission of delivering actionable clinical information to guide cancer diagnosis and therapy.
- Natera: Molecular diagnostics company with oncology and urology-relevant testing (e.g., Signatera MRD). Comparable as a specialty lab delivering high-sensitivity molecular and oncology testing to referring physicians and patients.
- NeoGenomics: Specialty oncology-focused clinical laboratory providing oncology and hematopathology testing services to community practices, hospitals, and pharma clients. Closely comparable as a specialty cancer diagnostics lab serving urology, GI, and similar practice segments.
- Exact Sciences: Cancer screening and diagnostics company with non-invasive colorectal cancer screening and oncology testing products. Comparable focus on non-invasive early cancer detection and personalized treatment guidance.
- Caris Life Sciences: Oncology diagnostics company offering molecular profiling and pathology services that guide cancer treatment decisions. Directly comparable mission of delivering actionable clinical information to guide diagnosis and personalized therapy.
- Guardant Health: Specialty oncology diagnostics company focused on liquid biopsy and precision oncology testing for advanced cancer patients. Comparable as a cancer diagnostic information provider targeting oncologists with precision medicine and treatment guidance.
Broad incumbents
- Quest Diagnostics: Largest US clinical reference laboratory offering a broad oncology and anatomic pathology menu, including urology and gastroenterology testing. Directly comparable as a competing provider to physicians and health systems, but at vastly greater scale and scope.
- Sonic Healthcare USA: International clinical pathology provider with US anatomic pathology and reference lab operations, including specialty urology and GI pathology services. Comparable as a multi-specialty clinical and anatomic pathology competitor.
- Laboratory Corporation of America (LabCorp): National clinical and anatomic pathology laboratory serving physicians, hospitals, and pharma clients. Overlaps with Freedom Pathology Partners in urological, GI, and women's health pathology testing and competes for the same referring practice relationships.
Emerging players
- PathAI: AI-powered pathology company developing digital diagnostics and machine-learning tools for cancer detection. Partially comparable as a technology-enabled cancer pathology player targeting similar oncologist and pathologist workflows.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Freedom Pathology Partners social profiles
Digital presenceFreedom Pathology Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Freedom Pathology Partners leadership team
Management profileNumber of profiles
Profiles1 record
Freedom Pathology Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Freedom Pathology Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Freedom Pathology Partners
What does Freedom Pathology Partners do?
Freedom Pathology Partners operates a world-class cancer diagnostic laboratory as part of the EmeritusDX network under Emeritus Medical Technology. The company performs diagnostic testing that guides the diagnosis and treatment of cancer patients across multiple specialties including dermatopathology, gastroenterology, hematopathology, urology, and women's health. It also provides infectious disease testing and pharmaceutical informatics and lab services.
When was Freedom Pathology Partners founded?
Freedom Pathology Partners was founded in 2014. It employs 11 to 50 people.
Where is Freedom Pathology Partners based?
Freedom Pathology Partners is headquartered in Conshohocken, United States, in the North America region.
Who are Freedom Pathology Partners's main competitors?
Direct peers on record are Foundation Medicine, Natera, NeoGenomics, Exact Sciences, Caris Life Sciences and Guardant Health. Broad incumbents are Quest Diagnostics, Sonic Healthcare USA and Laboratory Corporation of America (LabCorp). PathAI is listed as an emerging player.
Does Freedom Pathology Partners have an API?
No public API is recorded for Freedom Pathology Partners.
What industry is Freedom Pathology Partners in?
Freedom Pathology Partners's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAKAN, Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers, with a secondary code of HLAAALAE, Oncology Diagnostics (tumor profiling, MRD, liquid biopsy). Its NAICS code is 621511 and its SIC code is 8071.